Scarica l'app Stockscreener
106.45
1.34%
1.41
Dopo l'orario di chiusura:
106.20
-0.25
-0.23%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Merck Co Inc Borsa (MRK) Ultime notizie
Merck & Co. (MRK) Enters 2026 in the Spotlight: BMO Upgrade to $130, FDA Fast-Track Vouchers and TrumpRx Pricing Deal Reframe the Post-Keytruda Story - ts2.tech
Merck (MRK) Stock News on Dec. 25, 2025: BMO Lifts Target to $130 as FDA Fast-Track Vouchers and Keytruda Data Fuel Momentum - ts2.tech
Bar Harbor Wealth Management Buys 14,147 Shares of Merck & Co., Inc. $MRK - MarketBeat
A Tax Auditor's Secret to Building a $22 Million Fortune - The Motley Fool
Merck & Co., Inc. (NYSE:MRK) Sets New 12-Month HighWhat's Next? - MarketBeat
Vontobel Holding Ltd. Increases Holdings in Merck & Co., Inc. $MRK - MarketBeat
Hanson & Doremus Investment Management Lowers Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Swedbank AB Grows Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Farther Finance Advisors LLC - MarketBeat
Merck & Co., Inc (NYSE:MRK) S&P 500 Companies Biotech Footprint - Kalkine Media
Check Out What Whales Are Doing With MRK - Benzinga
Wall Street Analysts Think Merck (MRK) Is a Good Investment: Is It? - Finviz
Yousif Capital Management LLC Lowers Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Matrix Trust Co - MarketBeat
HBK Sorce Advisory LLC Acquires 16,271 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by OFI Invest Asset Management - MarketBeat
Cliftonlarsonallen Wealth Advisors LLC Buys 13,414 Shares of Merck & Co., Inc. $MRK - MarketBeat
"Merck (MRK) is an Inexpensive Stock," Says Jim Cramer - Finviz
“Merck (MRK) is an Inexpensive Stock,” Says Jim Cramer - Yahoo Finance
Brighton Jones LLC Buys 20,086 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Position Lessened by Baldwin Wealth Partners LLC MA - MarketBeat
Merck (MRK) Stock: What to Know Before the Market Opens on Dec. 22, 2025 - ts2.tech
Lineweaver Wealth Advisors LLC Has $3.18 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Viking Fund Management LLC Purchases 19,000 Shares of Merck & Co., Inc. $MRK - MarketBeat
Fluent Financial LLC Buys New Holdings in Merck & Co., Inc. $MRK - MarketBeat
Foster Victor Wealth Advisors LLC Grows Position in Merck & Co., Inc. $MRK - MarketBeat
Douglas Lane & Associates LLC Has $45.27 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck Reaches Agreement With U.S. Government to Expand Access to Medicines and Lower Costs for Americans - Business Wire
Rahway-Based Merck & Co., Inc. Recognized at 46th Annual Edison Patent Awards - TAPinto
Voya Investment Management LLC Has $57.55 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Perpetual Ltd - MarketBeat
Secure Asset Management LLC Lowers Stake in Merck & Co., Inc. $MRK - MarketBeat
Cyndeo Wealth Partners LLC Has $10.11 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Trump Secures Drug Price Cuts From 9 Major Pharma Firms Including Bristol Myers, Gilead, Merck In Medicaid Deal - Benzinga
Merck (MRK) Stock After Hours on Dec. 19, 2025: Trump Drug-Pricing Deal, FDA Fast-Track Vouchers, and What to Watch Before Markets Reopen - ts2.tech
Top Research Reports for NVIDIA, Netflix & Merck - TradingView — Track All Markets
US FDA grants priority vouchers to Merck's cholesterol pill, cancer therapy - Reuters
Patient deaths prompt halt in Merck-Daiichi phase III in lung cancer - BioWorld MedTech
Better Buy in 2026: Pfizer or Merck? - Finviz
Merck & Co Inc (MRK) Stock Price, Trades & News - GuruFocus
Merck (MRK) Stock News and Forecasts for Dec. 19, 2025: Drug-Pricing Deals, FDA Fast-Track Catalysts, and Wall Street Targets - ts2.tech
Evaxion Seeks New Partner For Gonorrhea Vaccine After Merck Opts Out - Benzinga
Merck Is Partnering With America’s Largest HBCU To Launch a Collaborative Biotechnology Learning Center - CSRwire
Merck (MRK)'s CEO Has a "Better Hand," Says Jim Cramer - Finviz
Merck (MRK)’s CEO Has a “Better Hand,” Says Jim Cramer - Insider Monkey
Trump to announce new deals to lower drug prices, White House says - Reuters
Merck & Co., Inc. $MRK Stock Holdings Boosted by Talbot Financial LLC - MarketBeat
Merck & Co., Inc. : Technically solid - marketscreener.com
Merck's Deep Pipeline And Cash Flow Strength Support The Bull Case - Seeking Alpha
Merck & Co., Inc. (NYSE:MRK) Stock Price Up 1.6% Following Analyst Upgrade - MarketBeat
Merck & Company, Inc. (MRK) Stock News and Forecasts: FDA Fast-Track Signals, BMO Upgrade, and a New Keytruda–Padcev Win (Dec. 18, 2025) - ts2.tech
Merck Cholesterol, Cancer Drugs May Enter FDA Fast-Track Program: Report - Benzinga
Merck & Co., Inc. (NYSE:MRK) Upgraded at BMO Capital Markets - MarketBeat
FDA Mulls National Priority Vouchers for Two Potential Merck Blockbusters: Report - BioSpace
Here Are Thursday’s Top Wall Street Analyst Research Calls: Digital Realty, GE Vernova, Micron Technology, Merck & Co., Rivian, United Airlines, and More - 24/7 Wall St.
27,329 Shares in Merck & Co., Inc. $MRK Purchased by Montecito Bank & Trust - MarketBeat
Thurston Springer Miller Herd & Titak Inc. Lowers Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
BMO Capital Upgrades Merck & Co. to Outperform From Market Perform, Adjusts PT to $130 From $82 - marketscreener.com
Czech National Bank Boosts Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co Inc (NYSE:MRK) S&P 500 Futures Healthcare Scale Research - Kalkine Media
Merck & Co., Inc. (NYSE:MRK) Shares Acquired Rep. Gilbert Ray Cisneros, Jr. - MarketBeat
Merck (MRK) Stock After Hours: FDA Fast‑Track Vouchers, Keytruda‑Padcev Trial Win, and What to Watch Before the Dec. 18 Market Open - ts2.tech
Merck & Co., Inc. (MRK) sees mixed analyst views as Europe advances WINREVAIR review - MSN
Merck & Co., Inc. (MRK) Sees Mixed Analyst Views as Europe Advances WINREVAIR Review - Insider Monkey
Merck cholesterol, cancer therapies to receive national priority vouchersreport - Seeking Alpha
Exclusive-US FDA taps Merck drugs with blockbuster sales potential for national priority vouchers - Yahoo Finance
Why Merck Co Inc Common Stock 6MK0 stock stays undervaluedQuarterly Risk Review & Risk Controlled Stock Alerts - moha.gov.vn
BofA Turns More Positive on Merck (MRK) Pipeline - Finviz
Merck's Keytruda-Padcev Combo Boosts Survival In Pivotal Bladder Cancer Trial - Benzinga
Pfizer, Merck Are Boring Again: 2026 Investors Are Circling BackMerck & Co (NYSE:MRK), Pfizer (NYSE:PFE) - Benzinga
0.18%
1.84%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):